Tactile Systems Technology (TCMD) Projected to Post Quarterly Earnings on Tuesday

Tactile Systems Technology (NASDAQ:TCMD) will likely be posting its Q4 2025 results after the market closes on Tuesday, February 17th. Analysts expect Tactile Systems Technology to post earnings of $0.44 per share and revenue of $93.7980 million for the quarter. Parties may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Tuesday, February 17, 2026 at 5:00 PM ET.

Tactile Systems Technology Trading Down 0.0%

NASDAQ TCMD opened at $26.45 on Monday. The company has a market cap of $590.89 million, a price-to-earnings ratio of 34.35 and a beta of 0.96. The company has a 50 day moving average of $29.02 and a 200-day moving average of $20.97. Tactile Systems Technology has a 1-year low of $8.61 and a 1-year high of $31.38.

Insider Activity at Tactile Systems Technology

In related news, VP Kristie Burns sold 5,139 shares of Tactile Systems Technology stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $28.85, for a total transaction of $148,260.15. Following the sale, the vice president directly owned 72,401 shares of the company’s stock, valued at approximately $2,088,768.85. The trade was a 6.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 2.50% of the company’s stock.

Institutional Trading of Tactile Systems Technology

A number of hedge funds have recently added to or reduced their stakes in the stock. Marshall Wace LLP bought a new position in shares of Tactile Systems Technology in the 4th quarter valued at $7,700,000. Federated Hermes Inc. increased its holdings in Tactile Systems Technology by 42.7% in the 2nd quarter. Federated Hermes Inc. now owns 551,561 shares of the company’s stock worth $5,593,000 after purchasing an additional 165,163 shares in the last quarter. Norges Bank bought a new position in Tactile Systems Technology in the second quarter valued at about $1,464,000. Counterpoint Mutual Funds LLC bought a new position in Tactile Systems Technology in the fourth quarter valued at about $3,391,000. Finally, Bridgeway Capital Management LLC boosted its stake in shares of Tactile Systems Technology by 297.3% during the third quarter. Bridgeway Capital Management LLC now owns 133,878 shares of the company’s stock valued at $1,853,000 after purchasing an additional 100,178 shares in the last quarter. Institutional investors and hedge funds own 83.43% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on TCMD. Zacks Research downgraded Tactile Systems Technology from a “strong-buy” rating to a “hold” rating in a research report on Monday, January 5th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Tactile Systems Technology in a research note on Monday, December 29th. Lake Street Capital increased their price objective on shares of Tactile Systems Technology from $23.50 to $32.00 and gave the stock a “buy” rating in a research note on Tuesday, November 4th. Wall Street Zen raised shares of Tactile Systems Technology from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 1st. Finally, Raymond James Financial set a $35.00 price target on shares of Tactile Systems Technology in a research report on Monday, January 5th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $28.75.

About Tactile Systems Technology

Tactile Systems Technology, Inc, headquartered in Plymouth, Minnesota, is a medical device company specializing in the design, manufacture and marketing of home-use pneumatic compression therapy systems for the treatment of lymphedema and other chronic edema-related conditions. Using proprietary software and patented pump technologies, the company’s platforms are designed to improve patient outcomes through sequential pressure treatment that promotes fluid mobilization and enhanced lymphatic function.

At the core of Tactile Systems’ product portfolio is the Flexitouch® system, a programmable pneumatic pump and garment system approved for home use, and the Aria® device, which features an intuitive touchscreen interface and advanced garment design.